首页 > 最新文献

Urology最新文献

英文 中文
Lymph Node Sampling in Pediatric Renal Tumors: Survey of Current Practices and Impact of Education 小儿肾脏肿瘤的淋巴结取样:当前做法调查及教育的影响。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.urology.2024.09.041
Kyle W. Szymanski , Rodrigo R. Pessoa , Joon Kyung Kim , Amanda F. Buchanan , Sarah L. Hecht , Jonathan P. Walker , Nicholas G. Cost

Objective

To characterize how often and to what extent surgeons are willing to perform retroperitoneal node sampling (RPLNS) for a unilateral renal tumor, and whether they would be encouraged to change goal number of LNs after “targeted education” (TE)

Methods

A survey with selected demographic and LN sampling practice questions was distributed to practicing members of the Society of Pediatric Urology (SPU). After answering a 7-question questionnaire, participants were provided with an abstract on the adequacy of LN yield for staging. This served as the TE and then participants were asked to answer a final question on LN sampling goals.

Results

A total of 76 (19.2%) of participants, out of 395 invitations, returned complete surveys. Cross tabulation between sampling goals before and after TE showed that among surgeons sampling 1-4 nodes, 13/24 (54.16%) would be willing to change their practice and sample ≥10 nodes. A higher proportion of participants who were already systematically surveilling 5-9 LNs would be willing to change their current practice: 30/39 (77%) would now aim for ≥10 LNs. On multivariate analysis, only willingness to sample ≥5 LNs in current practice was predictive of changing to sample ≥10 LNs after TE.

Conclusion

Retroperitoneal LNs are currently still under sampled by pediatric urologists operating on children and adolescents with unilateral renal tumors. TE appears to encourage change in LN sampling practices.
目的方法:向小儿泌尿外科学会 (SPU) 的执业会员发放了一份调查问卷,其中包含选定的人口统计学和 LN 取样实践问题。在回答了七道问题的问卷后,参与者会收到一份关于 LN 产量是否足以用于分期的摘要。该摘要作为TE,然后要求参与者回答关于LN取样目标的最后一个问题:在 395 位受邀者中,共有 76 位(19.2%)返回了完整的调查问卷。TE前后取样目标的交叉表显示,在取样1-4个结节的外科医生中,有13/24(54.16%)愿意改变做法,取样≥10个结节。在已经系统调查 5-9 个 LN 的参与者中,有更高比例的人愿意改变目前的做法:30/39(77%)的参与者现在的目标是≥10 个 LN。在多变量分析中,只有在当前实践中采样≥5个LNs的意愿才能预测在TE后是否会改为采样≥10个LNs:结论:目前,小儿泌尿科医生在对患有单侧肾肿瘤的儿童和青少年进行手术时,对腹膜后LN的取样仍然不足。有针对性的教育似乎有助于改变LN取样方法。
{"title":"Lymph Node Sampling in Pediatric Renal Tumors: Survey of Current Practices and Impact of Education","authors":"Kyle W. Szymanski ,&nbsp;Rodrigo R. Pessoa ,&nbsp;Joon Kyung Kim ,&nbsp;Amanda F. Buchanan ,&nbsp;Sarah L. Hecht ,&nbsp;Jonathan P. Walker ,&nbsp;Nicholas G. Cost","doi":"10.1016/j.urology.2024.09.041","DOIUrl":"10.1016/j.urology.2024.09.041","url":null,"abstract":"<div><h3>Objective</h3><div>To characterize how often and to what extent surgeons are willing to perform retroperitoneal node sampling (RPLNS) for a unilateral renal tumor, and whether they would be encouraged to change goal number of LNs after “targeted education” (TE)</div></div><div><h3>Methods</h3><div>A survey with selected demographic and LN sampling practice questions was distributed to practicing members of the Society of Pediatric Urology (SPU). After answering a 7-question questionnaire, participants were provided with an abstract on the adequacy of LN yield for staging. This served as the TE and then participants were asked to answer a final question on LN sampling goals.</div></div><div><h3>Results</h3><div>A total of 76 (19.2%) of participants, out of 395 invitations, returned complete surveys. Cross tabulation between sampling goals before and after TE showed that among surgeons sampling 1-4 nodes, 13/24 (54.16%) would be willing to change their practice and sample ≥10 nodes. A higher proportion of participants who were already systematically surveilling 5-9 LNs would be willing to change their current practice: 30/39 (77%) would now aim for ≥10 LNs. On multivariate analysis, only willingness to sample ≥5 LNs in current practice was predictive of changing to sample ≥10 LNs after TE.</div></div><div><h3>Conclusion</h3><div>Retroperitoneal LNs are currently still under sampled by pediatric urologists operating on children and adolescents with unilateral renal tumors. TE appears to encourage change in LN sampling practices.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"196 ","pages":"Pages 222-227"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Castration Levels of Testosterone Results in Atrophy of Androgen-sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism 睾酮阉割水平导致对雄激素敏感的会阴肌肉萎缩:男性性腺功能减退症的潜在生物标志物
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.urology.2024.10.006
Nityam Rathi , Zoë Blake , Jason Hyman , Daniel R. Nemirovsky , David G. Gelikman , Charles Hesswani , Christopher Koller , Daniel Nethala , Neil Mendhiratta , Alexander P. Kenigsberg , Jibriel Noun , William Dahut , Fatima Y. Karzai , W. Marston Linehan , Peter A. Pinto , Baris Turkbey , Sandeep Gurram

Objective

To evaluate MRI-based measurements of androgen-sensitive perineal/pelvic muscles in men with prostate cancer before and after androgen deprivation therapy (ADT) as a novel imaging marker for end-organ effects of hypogonadism. Diagnosing hypogonadism or testosterone deficiency (TD) requires both low serum testosterone and clinical symptoms, such as erectile dysfunction and reduced libido. However, the non-specific nature of many TD symptoms makes it challenging to initiate therapy. Objective markers of TD help to better identify patients who may benefit from testosterone supplementation; however, current markers, such as low bone mineral density, lack sensitivity. Previous studies suggest that decreased bulbocavernosus-muscle (BCM) thickness may be associated with TD, although it remains unclear if this is a correlative relationship.

Methods

Data were prospectively collected for patients with intermediate/high-risk localized prostate cancer enrolled in a phase II trial (NCT02430480). Patients received ADT before prostatectomy and underwent prostate MRI pre-/post-ADT. BCM, ischiocavernosus-muscle (ICM), and levator-ani-muscle (LAM) measurements were made using T2W-MRI. Paired t-tests evaluated changes in BCM/ICM/LAM width, and linear regression analyses evaluated relationships between changes in testosterone and muscle width.

Results

Thirty-eight consecutive patients with pre-/post-ADT MRIs were analyzed. Baseline testosterone was 286.5 ng/dL, and 36/38 patients had post-ADT testosterone <50 ng/dL. Pre-ADT and post-ADT measurements of the bilateral BCM/ICM/LAM width were 7.16 mm/7.95 mm/5.53 mm and 5.68 mm/6.71 mm/4.89 mm, respectively (P <.001). Decreases in testosterone predicted reduction in combined perineal muscle (BCM + ICM) width (P = .032).

Conclusion

Androgen deprivation led to significant and relatively rapid decreases in BCM/ICM/LAM thickness. This objective biomarker of low testosterone states may help identify patients who will potentially benefit from testosterone replacement.
目的评估前列腺癌男性患者在雄激素剥夺疗法(ADT)前后基于核磁共振成像对雄激素敏感的会阴/骨盆肌肉的测量结果,作为性腺功能减退症内脏影响的新型成像标记。诊断性腺功能减退症或睾酮缺乏症(TD)需要同时具备低血清睾酮和临床症状,如勃起功能障碍和性欲减退。然而,许多 TD 症状并不具有特异性,这给开始治疗带来了挑战。睾酮缺乏症的客观指标有助于更好地识别可能从补充睾酮中获益的患者;然而,目前的指标,如低骨矿物质密度,缺乏敏感性。以前的研究表明,球海绵体肌(BCM)厚度的减少可能与TD有关,但目前仍不清楚这是否是一种相关关系:前瞻性地收集了参加一项 II 期试验(NCT02430480)的中/高风险局部前列腺癌患者的数据。患者在前列腺切除术前接受 ADT,并在 ADT 前后接受前列腺 MRI 检查。使用 T2W-MRI 对 BCM、峡部肌 (ICM) 和左侧肌 (LAM) 进行了测量。配对 t 检验评估了 BCM/ICM/LAM 宽度的变化,线性回归分析评估了睾酮变化与肌肉宽度之间的关系:结果:分析了 38 名连续接受 ADT MRI 前后检查的患者。基线睾酮为 286.5ng/dl,其中 36/38 例患者的睾酮值在 ADT 后得出结论:雄激素剥夺导致 BCM/ICM/LAM 厚度显著且相对快速地下降。这种低睾酮状态的客观生物标志物可帮助识别可能从睾酮替代中获益的患者。
{"title":"Castration Levels of Testosterone Results in Atrophy of Androgen-sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism","authors":"Nityam Rathi ,&nbsp;Zoë Blake ,&nbsp;Jason Hyman ,&nbsp;Daniel R. Nemirovsky ,&nbsp;David G. Gelikman ,&nbsp;Charles Hesswani ,&nbsp;Christopher Koller ,&nbsp;Daniel Nethala ,&nbsp;Neil Mendhiratta ,&nbsp;Alexander P. Kenigsberg ,&nbsp;Jibriel Noun ,&nbsp;William Dahut ,&nbsp;Fatima Y. Karzai ,&nbsp;W. Marston Linehan ,&nbsp;Peter A. Pinto ,&nbsp;Baris Turkbey ,&nbsp;Sandeep Gurram","doi":"10.1016/j.urology.2024.10.006","DOIUrl":"10.1016/j.urology.2024.10.006","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate MRI-based measurements of androgen-sensitive perineal/pelvic muscles in men with prostate cancer before and after androgen deprivation therapy (ADT) as a novel imaging marker for end-organ effects of hypogonadism. Diagnosing hypogonadism or testosterone deficiency (TD) requires both low serum testosterone and clinical symptoms, such as erectile dysfunction and reduced libido. However, the non-specific nature of many TD symptoms makes it challenging to initiate therapy. Objective markers of TD help to better identify patients who may benefit from testosterone supplementation; however, current markers, such as low bone mineral density, lack sensitivity. Previous studies suggest that decreased bulbocavernosus-muscle (BCM) thickness may be associated with TD, although it remains unclear if this is a correlative relationship.</div></div><div><h3>Methods</h3><div>Data were prospectively collected for patients with intermediate/high-risk localized prostate cancer enrolled in a phase II trial (NCT02430480). Patients received ADT before prostatectomy and underwent prostate MRI pre-/post-ADT. BCM, ischiocavernosus-muscle (ICM), and levator-ani-muscle (LAM) measurements were made using T2W-MRI. Paired t-tests evaluated changes in BCM/ICM/LAM width, and linear regression analyses evaluated relationships between changes in testosterone and muscle width.</div></div><div><h3>Results</h3><div>Thirty-eight consecutive patients with pre-/post-ADT MRIs were analyzed. Baseline testosterone was 286.5<!--> <!-->ng/dL, and 36/38 patients had post-ADT testosterone &lt;50<!--> <!-->ng/dL. Pre-ADT and post-ADT measurements of the bilateral BCM/ICM/LAM width were 7.16<!--> <!-->mm/7.95<!--> <!-->mm/5.53<!--> <!-->mm and 5.68<!--> <!-->mm/6.71<!--> <!-->mm/4.89<!--> <!-->mm, respectively (<em>P</em> &lt;.001). Decreases in testosterone predicted reduction in combined perineal muscle (BCM<!--> <!-->+<!--> <!-->ICM) width (<em>P</em> = .032).</div></div><div><h3>Conclusion</h3><div>Androgen deprivation led to significant and relatively rapid decreases in BCM/ICM/LAM thickness. This objective biomarker of low testosterone states may help identify patients who will potentially benefit from testosterone replacement.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"196 ","pages":"Pages 313-320"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142475897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association Between Stone Heterogenicity and the Success of Shock Wave Lithotripsy for High Density Upper Urinary Tract Stones: A Muti-Center Prospective Cohort 结石异质性与冲击波碎石术治疗高密度上尿路结石成功率之间的关系:一项多中心前瞻性队列研究。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.urology.2024.10.069
Hanfeng Xu , Junlong Liu , Zheming Li , Chengshan Ge , Hongqiang Guo , Shiyu Song , Zhenhua Li , Song Bai

Objective

To prospectively investigate the predictive value of radiological stone heterogenicity for the success of shock-wave lithotripsy (SWL) in patients with high-density upper urinary tract stones.

Methods

This multi-center prospective study was conducted from June 2020 to December 2023. The radiological stone density index measured by computed tomography (CT) included the mean, standard deviation (SD), and coefficient variation (CV) of the Hounsfield Unit value of stones. The success was defined as no evidence of clinically significant stone fragments (≥4 mm) on a plain X-ray and ultrasound of the upper urinary tract 1 month after SWL. Binary logistic regression models were used to assess the odds ratios (ORs) and 95% confidence intervals (CIs).

Results

Finally, 533 patients with high-density upper urinary tract stones were enrolled in this study. There were 68.5% (379/533) patients experienced success after SWL treatment. After adjusted confounding variables, compared with the patients in the lowest quartile of stone density index, the odds ratios (95% CI) for the extreme quartile was 1.42 (0.71, 2.81, P for trend = .443), .03 (.01, .09, P for trend <.001), and .02 (.01, .07, P for trend <.001) for MSD, SD, and CV, respectively. Furthermore, this linear association was confirmed only for SD and CV regardless of gender, body mass index, stone size, and stone location.

Conclusion

This multi-center prospective study demonstrated a positive association between the stone heterogenicity and the success of SWL in patients with high-density upper urinary tract stones regardless of gender, body mass index, stone size, and stone location. However, this association was not observed in mean stone density.
目的前瞻性研究放射学结石异质性对高密度上尿路结石患者SWL成功率的预测价值:这项多中心前瞻性研究于 2020 年 6 月至 2023 年 12 月进行。CT 测量的放射性结石密度指数包括结石 HU 值的平均值、标准差(SD)和变异系数(CV)。SWL术后一个月的X光片和上尿路超声检查未发现有临床意义的结石碎片(≥ 4 mm)即为成功。采用二元逻辑回归模型评估几率比(ORs)和95%置信区间(CIs):共有533名高密度上尿路结石患者参与了这项研究。有68.5%(379/533)的患者在接受SWL治疗后获得成功。调整混杂变量后,与结石密度指数最低四分位数的患者相比,极端四分位数患者的MSD、SD和CV的OR(95% CI)分别为1.42(0.71,2.81,趋势P=0.443)、0.03(0.01,0.09,趋势P<0.001)和0.02(0.01,0.07,趋势P<0.001)。此外,无论性别、体重指数、结石大小和结石位置如何,只有SD和CV证实了这种线性关系:这项多中心前瞻性研究表明,无论性别、体重指数、结石大小和结石位置如何,高密度上尿路结石患者的结石异质性与SWL的成功率呈正相关。然而,在 MSD 中却未观察到这种关联。
{"title":"The Association Between Stone Heterogenicity and the Success of Shock Wave Lithotripsy for High Density Upper Urinary Tract Stones: A Muti-Center Prospective Cohort","authors":"Hanfeng Xu ,&nbsp;Junlong Liu ,&nbsp;Zheming Li ,&nbsp;Chengshan Ge ,&nbsp;Hongqiang Guo ,&nbsp;Shiyu Song ,&nbsp;Zhenhua Li ,&nbsp;Song Bai","doi":"10.1016/j.urology.2024.10.069","DOIUrl":"10.1016/j.urology.2024.10.069","url":null,"abstract":"<div><h3>Objective</h3><div>To prospectively investigate the predictive value of radiological stone heterogenicity for the success of shock-wave lithotripsy (SWL) in patients with high-density upper urinary tract stones.</div></div><div><h3>Methods</h3><div>This multi-center prospective study was conducted from June 2020 to December 2023. The radiological stone density index measured by computed tomography (CT) included the mean, standard deviation (SD), and coefficient variation (CV) of the Hounsfield Unit value of stones. The success was defined as no evidence of clinically significant stone fragments (≥4 mm) on a plain X-ray and ultrasound of the upper urinary tract 1 month after SWL. Binary logistic regression models were used to assess the odds ratios (ORs) and 95% confidence intervals (CIs).</div></div><div><h3>Results</h3><div>Finally, 533 patients with high-density upper urinary tract stones were enrolled in this study. There were 68.5% (379/533) patients experienced success after SWL treatment. After adjusted confounding variables, compared with the patients in the lowest quartile of stone density index, the odds ratios (95% CI) for the extreme quartile was 1.42 (0.71, 2.81, <em>P</em> for trend = .443), .03 (.01, .09, <em>P</em> for trend &lt;.001), and .02 (.01, .07, <em>P</em> for trend &lt;.001) for MSD, SD, and CV, respectively. Furthermore, this linear association was confirmed only for SD and CV regardless of gender, body mass index, stone size, and stone location.</div></div><div><h3>Conclusion</h3><div>This multi-center prospective study demonstrated a positive association between the stone heterogenicity and the success of SWL in patients with high-density upper urinary tract stones regardless of gender, body mass index, stone size, and stone location. However, this association was not observed in mean stone density.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"196 ","pages":"Pages 57-63"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142693718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Comment on “Vessel Sparing Nontransecting Anastomotic Reconstruction of the Posterior Urethra: Single-center Experience With Long-term Follow-up” 编辑评论"后尿道血管疏通非横切吻合术重建:单中心长期随访经验》(URL-D-24-01643R1)。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.urology.2024.11.038
Bridget L. Findlay, Boyd R. Viers
{"title":"Editorial Comment on “Vessel Sparing Nontransecting Anastomotic Reconstruction of the Posterior Urethra: Single-center Experience With Long-term Follow-up”","authors":"Bridget L. Findlay,&nbsp;Boyd R. Viers","doi":"10.1016/j.urology.2024.11.038","DOIUrl":"10.1016/j.urology.2024.11.038","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"196 ","pages":"Pages 290-291"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142740710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Editorial Comment on “Castration Levels of Testosterone Results in Atrophy of Androgen-sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism” 作者回复。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.urology.2024.11.055
Sandeep Gurram, Nityam Rathi
{"title":"Reply to Editorial Comment on “Castration Levels of Testosterone Results in Atrophy of Androgen-sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism”","authors":"Sandeep Gurram,&nbsp;Nityam Rathi","doi":"10.1016/j.urology.2024.11.055","DOIUrl":"10.1016/j.urology.2024.11.055","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"196 ","pages":"Pages 323-324"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142795237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor on “The Diagnostic Efficacy of Rapid Urine Sediment Fluorescence Staining in Urinary Tract Infections: An Exploratory Study” 致编辑的信:“社会脆弱性与女性更严重的尿失禁和生活质量有关”。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.urology.2024.12.025
Yi Xu MM , Jiafei Jin MM
{"title":"Letter to the Editor on “The Diagnostic Efficacy of Rapid Urine Sediment Fluorescence Staining in Urinary Tract Infections: An Exploratory Study”","authors":"Yi Xu MM ,&nbsp;Jiafei Jin MM","doi":"10.1016/j.urology.2024.12.025","DOIUrl":"10.1016/j.urology.2024.12.025","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"196 ","pages":"Pages 73-74"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142898524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aims and Scope
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-02-01 DOI: 10.1016/S0090-4295(25)00066-4
{"title":"Aims and Scope","authors":"","doi":"10.1016/S0090-4295(25)00066-4","DOIUrl":"10.1016/S0090-4295(25)00066-4","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"196 ","pages":"Page A1"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143311677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Off-the-Shelf Implant to Bridge a Urethral Defect: Multicenter 8-Year Journey From Bench to Bed 现成的植入物桥接尿道缺损:多中心8年从长凳到床的历程。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.urology.2024.12.016
Ganesh Vythilingam , Hans M. Larsson , Wei Sien Yeoh , Saiful Azli Mohd Zainuddin , Eva-Maria Engelhardt , Anand Sanmugam , Yau Lun Ch’ng , Yi Xian Foong , Muhd Khairul Akmal Wak Harto , Kalitha Pinnagoda , Hui Cheng Chen , Rozanaliza Radzi , Mark Hiew , Nurul Hayah Khairuddin , Retnagowri Rajandram , Selvalingam Sothilingam , Thambidorai Conjeevaram Rajendrarao , Tunku Kamarul Zaman Tunku Zainol Abidin , Jeffrey A. Hubbell , Peter Frey , Teng Aik Ong

Objective

To engineer an acellular mesh to reconstruct the urethra to replace the current surgical practice of using autologous tissue grafts. Cell based approaches have shown progress. However, these have been associated with high costs and logistical challenges.

Materials and Methods

Acellular meshes were engineered using liquid collagen. They underwent in vitro, mechanical and bench testing by surgeons. Sixty-nine male New Zealand rabbits were used to refine the design. The final prototype based on the TissueSpan patented technology was then implanted again in a 2 cm long urethral defect in 9 rabbits and in a 4 cm long defect in 6 dogs.

Results

The TissueSpan technology platform allows for the manufacturing of tubular and rectangular meshes in different diameters and thicknesses. The tubular mesh acted as physical conduit to gap the urethral defect with a patent urethra demonstrated after 1 month in both animal models. The mesh was absorbed within 1-3 months. Spontaneous urothelial coverage of the mesh and smooth muscle cell migration into the surgical area was demonstrated even in a 4 cm long urethral defect. A first in man clinical trial was subsequently initiated.

Conclusion

The acellular mesh may have the potential to be an off-the-shelf product for substitution urethroplasty. Its mechanical properties allow surgeons to easily create a physical conduit while its material properties favor tissue remodeling. A large-scale clinical trial is still required to further confirm the safety, performance, and patient benefit of this new medical device.
目的:设计无细胞补片重建尿道,以取代目前自体组织移植尿道的手术方法。基于细胞的方法已经取得了进展。然而,这些都伴随着高成本和后勤挑战。材料与方法:采用液体胶原蛋白制备脱细胞网。他们接受了外科医生的体外、机械和台架测试。69只雄性新西兰兔被用来完善设计。然后,基于TissueSpan专利技术的最终原型再次被植入9只兔子的2厘米长的尿道缺损和6只狗的4厘米长的尿道缺损中。结果:TissueSpan技术平台可以制造不同直径和厚度的管状和矩形网格。1个月后,两种动物模型均显示管状网作为物理导管将尿道缺损与未闭尿道隔开。补片在1-3个月内被吸收。即使在4cm长的尿道缺损中,尿路上皮对补片的覆盖和平滑肌细胞向手术区域的迁移也被证明是自发的。随后进行了首次人体临床试验。结论:脱细胞补片有可能成为替代尿道成形术的现成产品。它的机械性能使外科医生能够轻松地创建一个物理导管,而它的材料特性有利于组织重塑。还需要大规模的临床试验来进一步确认这种新型医疗设备的安全性、性能和患者益处。
{"title":"Off-the-Shelf Implant to Bridge a Urethral Defect: Multicenter 8-Year Journey From Bench to Bed","authors":"Ganesh Vythilingam ,&nbsp;Hans M. Larsson ,&nbsp;Wei Sien Yeoh ,&nbsp;Saiful Azli Mohd Zainuddin ,&nbsp;Eva-Maria Engelhardt ,&nbsp;Anand Sanmugam ,&nbsp;Yau Lun Ch’ng ,&nbsp;Yi Xian Foong ,&nbsp;Muhd Khairul Akmal Wak Harto ,&nbsp;Kalitha Pinnagoda ,&nbsp;Hui Cheng Chen ,&nbsp;Rozanaliza Radzi ,&nbsp;Mark Hiew ,&nbsp;Nurul Hayah Khairuddin ,&nbsp;Retnagowri Rajandram ,&nbsp;Selvalingam Sothilingam ,&nbsp;Thambidorai Conjeevaram Rajendrarao ,&nbsp;Tunku Kamarul Zaman Tunku Zainol Abidin ,&nbsp;Jeffrey A. Hubbell ,&nbsp;Peter Frey ,&nbsp;Teng Aik Ong","doi":"10.1016/j.urology.2024.12.016","DOIUrl":"10.1016/j.urology.2024.12.016","url":null,"abstract":"<div><h3>Objective</h3><div>To engineer an acellular mesh to reconstruct the urethra to replace the current surgical practice of using autologous tissue grafts. Cell based approaches have shown progress. However, these have been associated with high costs and logistical challenges.</div></div><div><h3>Materials and Methods</h3><div>Acellular meshes were engineered using liquid collagen. They underwent in vitro, mechanical and bench testing by surgeons. Sixty-nine male New Zealand rabbits were used to refine the design. The final prototype based on the TissueSpan patented technology was then implanted again in a 2 cm long urethral defect in 9 rabbits and in a 4 cm long defect in 6 dogs.</div></div><div><h3>Results</h3><div>The TissueSpan technology platform allows for the manufacturing of tubular and rectangular meshes in different diameters and thicknesses. The tubular mesh acted as physical conduit to gap the urethral defect with a patent urethra demonstrated after 1<!--> <!-->month in both animal models. The mesh was absorbed within 1-3<!--> <!-->months. Spontaneous urothelial coverage of the mesh and smooth muscle cell migration into the surgical area was demonstrated even in a 4 cm long urethral defect. A first in man clinical trial was subsequently initiated.</div></div><div><h3>Conclusion</h3><div>The acellular mesh may have the potential to be an off-the-shelf product for substitution urethroplasty. Its mechanical properties allow surgeons to easily create a physical conduit while its material properties favor tissue remodeling. A large-scale clinical trial is still required to further confirm the safety, performance, and patient benefit of this new medical device.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"196 ","pages":"Pages 294-299"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Multimodal Treatment of Uterine Rhabdomyosarcoma 子宫横纹肌肉瘤多模式治疗成功。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.urology.2024.12.020
Meghan F. Davis, Thomas F. Kolon, Christopher J. Long
Uterine rhabdomyosarcoma is exceedingly rare. The treatment strategy has evolved from aggressive local control with upfront surgery followed by radiation to a more conservative approach with chemotherapy followed by additional treatment pending response, which is outlined in a recent consensus statement from the International Soft-Tissue Sarcoma Consortium. We present a case of a 2-year-old with intermediate risk uterine rhabdomyosarcoma. She was treated with a multimodal regimen including chemotherapy, radiation, and surgery with abdominal hysterectomy, bilateral salpingectomy, oophoropexy, partial proximal vaginectomy, and right extravesical nonrefluxing ureteral reimplant to achieve a complete resection.
子宫RMS极为罕见。治疗策略已经从积极的局部控制(前期手术后放疗)发展到更保守的化疗后附加治疗等待反应,国际软组织肉瘤协会最近的共识声明中概述了这一点。3我们报告了一个2岁的中度危险子宫RMS病例。她接受了包括化疗、放疗和手术在内的多模式治疗方案,包括腹部子宫切除术、双侧输卵管切除术、卵巢切除术、部分阴道近端切除术和右侧非返流输尿管外再植入术,以实现完全切除。
{"title":"Successful Multimodal Treatment of Uterine Rhabdomyosarcoma","authors":"Meghan F. Davis,&nbsp;Thomas F. Kolon,&nbsp;Christopher J. Long","doi":"10.1016/j.urology.2024.12.020","DOIUrl":"10.1016/j.urology.2024.12.020","url":null,"abstract":"<div><div>Uterine rhabdomyosarcoma is exceedingly rare. The treatment strategy has evolved from aggressive local control with upfront surgery followed by radiation to a more conservative approach with chemotherapy followed by additional treatment pending response, which is outlined in a recent consensus statement from the International Soft-Tissue Sarcoma Consortium. We present a case of a 2-year-old with intermediate risk uterine rhabdomyosarcoma. She was treated with a multimodal regimen including chemotherapy, radiation, and surgery with abdominal hysterectomy, bilateral salpingectomy, oophoropexy, partial proximal vaginectomy, and right extravesical nonrefluxing ureteral reimplant to achieve a complete resection.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"196 ","pages":"Pages 218-221"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142898534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Absence of Race/Ethnicity Reporting in Clinical Trials of True Minimally Invasive Surgical Therapies for the Treatment of Benign Prostatic Hyperplasia 在治疗良性前列腺增生症的真正微创手术疗法的临床试验中没有种族/族裔报告。
IF 2.1 3区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.urology.2024.09.043
Anna-Lisa V. Nguyen , Mahmoud Moustafa , David-Dan Nguyen , David Bouhadana , Tuan Thanh Nguyen , Bilal Chughtai , Dean S. Elterman , Christopher J.D. Wallis , Quoc-Dien Trinh , Naeem Bhojani

Objective

To assess the extent of racial reporting and enrollment in randomized controlled trials (RCTs) of minimally invasive surgical therapies (MIST) for the office-based treatment of benign prostatic hyperplasia (BPH).

Methods

A systematic review was conducted for RCTs assessing 6 office-based MISTs: transurethral microwave thermotherapy (TUMT), prostatic artery embolization, prostatic urethral lift, temporary implantable nitinol device, water vapor thermal therapy, and Optilume. MEDLINE, Embase, and the Cochrane CENTRAL databases were searched up to November 3, 2023. Publications were excluded if they (1) did not address one of the aforementioned office-based MISTs for the treatment of BPH; (2) were not RCTs; (3) were an abstract or conference proceeding; or (4) were not published in English. In addition to study characteristics, data about racial reporting were collected. Two independent reviewers completed screening at title, abstract, and full-text levels, with conflicts resolved by consensus with a third reviewer.

Results

A total of 61 publications representing 37 unique RCTs (n = 4027 unique patients) were reviewed, with publication years spanning from 1993 to 2023. TUMT was the most frequently studied MIST. Most publications (79%) were based solely in Europe or North America. Over 50% of the publications were multicenter trials. None of the included publications reported on race/ethnicity of study participants.

Conclusion

None of the 61 included publications of RCTs of office-based MISTs provided information on racial/ethnic composition of study participants. There is a staggering gap in the standardization of race/ethnicity reporting and enrollment within RCTs of MISTs. More granular data on race/ethnicity allow for better generalizability and equity.
目的:目的:评估以诊室为基础治疗良性前列腺增生症(BPH)的微创手术疗法(MIST)的 RCT 的种族报告和入组程度:对评估六种诊室微创手术疗法的 RCT 进行了系统回顾:经尿道微波热疗、前列腺动脉栓塞术、前列腺尿道提升术、临时植入式镍钛诺装置、水蒸气热疗和 Optilume。对MEDLINE、Embase和Cochrane CENTRAL数据库的检索截止到2023年11月3日。排除了以下文献:1)未涉及上述用于治疗良性前列腺增生症的诊室 MIST;2)非 RCT;3)摘要或会议论文集;或 4)非英文发表。除研究特点外,还收集了有关种族报告的数据。两名独立审稿人完成了标题、摘要和全文的筛选,并与第三名审稿人达成共识以解决冲突:结果:共审查了61篇文献,其中包括37项RCT研究(n=4027名患者),发表时间跨度为1993年至2023年。TUMT是最常被研究的MIST。大多数论文(79%)仅发表于欧洲或北美。50%以上的出版物为多中心试验。所收录的文献均未报告研究参与者的种族/族裔:结论:在收录的 61 篇关于基于诊室的 MIST 的 RCTs 文献中,没有一篇提供了研究参与者的种族/民族构成信息。在 MIST 的 RCTs 中,种族/民族报告和注册的标准化程度存在巨大差距。有关种族/族裔的更详细数据可提高可推广性和公平性。
{"title":"Absence of Race/Ethnicity Reporting in Clinical Trials of True Minimally Invasive Surgical Therapies for the Treatment of Benign Prostatic Hyperplasia","authors":"Anna-Lisa V. Nguyen ,&nbsp;Mahmoud Moustafa ,&nbsp;David-Dan Nguyen ,&nbsp;David Bouhadana ,&nbsp;Tuan Thanh Nguyen ,&nbsp;Bilal Chughtai ,&nbsp;Dean S. Elterman ,&nbsp;Christopher J.D. Wallis ,&nbsp;Quoc-Dien Trinh ,&nbsp;Naeem Bhojani","doi":"10.1016/j.urology.2024.09.043","DOIUrl":"10.1016/j.urology.2024.09.043","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the extent of racial reporting and enrollment in randomized controlled trials (RCTs) of minimally invasive surgical therapies (MIST) for the office-based treatment of benign prostatic hyperplasia (BPH).</div></div><div><h3>Methods</h3><div>A systematic review was conducted for RCTs assessing 6 office-based MISTs: transurethral microwave thermotherapy (TUMT), prostatic artery embolization, prostatic urethral lift, temporary implantable nitinol device, water vapor thermal therapy, and Optilume. MEDLINE, Embase, and the Cochrane CENTRAL databases were searched up to November 3, 2023. Publications were excluded if they (1) did not address one of the aforementioned office-based MISTs for the treatment of BPH; (2) were not RCTs; (3) were an abstract or conference proceeding; or (4) were not published in English. In addition to study characteristics, data about racial reporting were collected. Two independent reviewers completed screening at title, abstract, and full-text levels, with conflicts resolved by consensus with a third reviewer.</div></div><div><h3>Results</h3><div>A total of 61 publications representing 37 unique RCTs (n = 4027 unique patients) were reviewed, with publication years spanning from 1993 to 2023. TUMT was the most frequently studied MIST. Most publications (79%) were based solely in Europe or North America. Over 50% of the publications were multicenter trials. None of the included publications reported on race/ethnicity of study participants.</div></div><div><h3>Conclusion</h3><div>None of the 61 included publications of RCTs of office-based MISTs provided information on racial/ethnic composition of study participants. There is a staggering gap in the standardization of race/ethnicity reporting and enrollment within RCTs of MISTs. More granular data on race/ethnicity allow for better generalizability and equity.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"196 ","pages":"Pages 300-308"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1